Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Busen Wang
Observed names:
Bu-Sen Wang,
Wang, Busen
Institution:
Academy of Military Medical Sciences
Observed institution:
Academy of Military Medical Sciences
ORCID:
0000-0001-9041-1919
Observed ORCID:
0000-0001-9041-1919
OpenAlex ID:
A5080770846
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
2020
·
Feng-Cai Zhu
, Xu-Hua Guan
, et al.
·
The Lancet
·
1,324
PDF
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
2021
·
Shipo Wu
, Jianying Huang
, et al.
·
The Lancet Infectious Diseases
·
300
PDF
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
2020
·
Shipo Wu
, Gongxun Zhong
, et al.
·
Nature Communications
·
282
PDF
Seroepidemiological investigation of HAdV-4 infection among healthy adults in China and in Sierra Leone, West Africa
2018
·
Busen Wang
, Jianhua Li
, et al.
·
Emerging Microbes & Infections
·
123
PDF
Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized Trial
2022
·
Rong Tang
, Hui Zheng
, et al.
·
The Lancet Respiratory Medicine
·
69
PDF
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models
2018
·
Qiang Guo
, Jasper Fuk-Woo Chan
, et al.
·
The Journal of Infectious Diseases
·
59
PDF
Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus
2022
·
Zhe Zhang
, ZhengHao Zhao
, et al.
·
Frontiers in Immunology
·
30
PDF
PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71
2017
·
Zhe Zhang
, Busen Wang
, et al.
·
Virology
·
23
PDF
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
2022
·
Xiangyang Chi
, Yingying Guo
, et al.
·
Signal Transduction and Targeted Therapy
·
21
PDF
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study
2023
·
Tao Huang
, Sheng Zhang
, et al.
·
The Lancet Respiratory Medicine
·
19
PDF
Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients
2023
·
Zhe Zhang
, Shipo Wu
, et al.
·
Frontiers in Immunology
·
17
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge
2022
·
Ting Bian
, Busen Wang
, et al.
·
Frontiers in Immunology
·
16
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
2022
·
Zhe Zhang
, Shipo Wu
, et al.
·
medRxiv
·
16
PDF
Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial
2023
·
Jia-Wei Xu
, Bu-Sen Wang
, et al.
·
Emerging Microbes & Infections
·
14
PDF
Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect
2024
·
Kai Shen
, Jinlong Zhang
, et al.
·
International Journal of Pharmaceutics
·
13
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs
2022
·
Busen Wang
, Jinghan Xu
, et al.
·
Signal Transduction and Targeted Therapy
·
12
PDF
Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial
2025
·
Shipo Wu
, Jianying Huang
, et al.
·
Nature Communications
·
10
PDF
Monovalent XBB.1.5 booster vaccination induces a broad spectrum of SARS-CoV-2 neutralizing antibodies
2023
·
Nan Huo
, Shipo Wu
, et al.
·
Emerging Microbes & Infections
·
10
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice
2023
·
Yudong Wang
, Busen Wang
, et al.
·
Viruses
·
9
PDF
A seroepidemiological survey of adenovirus type 7 circulation among healthy adults in China and in Sierra Leone, West Africa
2023
·
Busen Wang
, Jianhua Li
, et al.
·
Frontiers in Public Health
·
9
Molecular basis of Ad5-nCoV vaccine-induced immunogenicity
2025
·
Dongyang Dong
, Yutong Song
, et al.
·
Structure
·
8
Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage
2022
·
Tiecheng Wang
, Faming Miao
, et al.
·
Frontiers in Immunology
·
7
PDF
Design and construction of a fast synthetic modified vaccinia virus Ankara reverse genetics system for advancing vaccine development
2025
·
Zhiqiang Gao
, Busen Wang
, et al.
·
Frontiers in Microbiology
·
5
PDF
Development of a novel adenovirus type 4 vector as a promising respiratory vaccine vehicle
2025
·
Jinghan Xu
, Busen Wang
, et al.
·
Frontiers in Immunology
·
4
Gut-initiated mucosal and systemic immunity against SARS-CoV-2 via an oral hyaluronic acid/chitosan vaccine coacervate
2025
·
Shunyi Li
, Shengyuan Huo
, et al.
·
Journal of Controlled Release
·
3
Show more works
View as search
Works count:
37
Citation count:
2,414
H-index:
14
I10-index:
18
Year
Topic
Type